Overview
- The Autorité de la concurrence sanctioned Doctolib for imposing exclusivity on healthcare professionals, tying teleconsultation to its booking software, and acquiring MonDocteur to lock the national market.
- The decision is executable right away, with Doctolib ordered to pay the €4.665 million fine to the public treasury and to cease the identified practices, subject to recovery with interest if it wins on appeal.
- Investigators cited internal documents seized in 2021, including notes describing plans to “killer le produit” and eliminate MonDocteur as a rival.
- Regulators found Doctolib holds roughly 70–90% of online booking and over 40% of teleconsultation, and they pointed to successive price increases after the 2018 acquisition.
- Doctolib said it will appeal, disputes that it is dominant, claims only about 30% of French practitioners are equipped, defends product integration, and says exclusivity clauses were removed around 2023.